BARDA at BTEC Overview
The Golden LEAF Biomanufacturing Training and Education Center (BTEC) at NC State University provides training for selected employees of global influenza vaccine manufacturers. Countries that have participated in this program include Egypt, India, Indonesia, Kazakhstan, Mexico, Romania, Russia, Serbia, South Africa, South Korea, Thailand, and Vietnam. Funding for this program comes from U.S. Department of Health and Human Services Biomedical Advanced Research and Development Authority (BARDA).
BTEC will offer three (3) courses during 2013:
- Fundamentals of cGMP Influenza Vaccine Manufacturing
(April-May 2013) and (July-August 2013)
- Advanced Upstream Processes for Influenza Vaccine Manufacturing (June 2013)
- Advanced Downstream Processes for Influenza Vaccine Manufacturing (June 2013)
The GTI is proud to partner with BTEC on this important global health program and will provide and arrange logistical services (participant selection, transportation, visa documentation, orientation, housing, meals, cultural programs, etc.,) for BTEC and the BARDA program participants.
Information for Training Candidates
All candidates must meet the following criteria:
- Fluent in English (able to read, write, speak, and understand spoken English).
- Currently employed by an institution receiving support from BARDA and/or WHO for the international vaccine production capacity-building program.
- Have a background in biological sciences or engineering and/or experience in the manufacturing of vaccines or biologicals
Applications are closed. Please check back later once we re-open the application process.
Find the answers to the Frequently Asked Questions (FAQ) for BARDA participants
Pre-arrival information for BARDA participants
Guide for BARDA participants coming to NC State
BTEC (for training content)
Dr. Jennifer Ruiz, Assistant Director, Bioprocess Services and BARDA training program manager
GTI (for logistics)
Mr. Michael Bustle, GTI Director
Ilin Misaras, GTI Training Program Coordinator for BTEC programs
BARDA and BTEC Background
Beginning in September 2010, BTEC has received annual grant awards as part of a five-year, nearly $5 million project funded by the Biomedical Advanced Research and Development Authority (BARDA), which is part of the U.S. Department of Health and Human Services. With funding from this grant, a team of instructors from BTEC, Duke University, and industry provided a three-week course entitled Fundamentals of cGMP Influenza Vaccine Manufacturing to three different groups of trainees from February through June 2011. Trainees were selected by institutions participating in a U.S. government-sponsored program to build vaccine production capacity among countries with developing economies. In 2012, the program expanded to offer two additional courses in advanced upstream and advanced downstream processing. These three courses are offered again in 2013.